. . . actually, tg4 . . . PFE did miss, but most of pharma and biotech were in the toilet today . . . share price will likely rebound in the near-term, sales will continue to grow, and -- as has been the case in recent years -- the board will probably vote a bigger dividend for next year . . . what's not to like? . . . good luck . . .